The use of bupropion metabolites for the treatment of inflammatory disorders

Details for Australian Patent Application No. 2007222217 (hide)

Owner Biocopea Limited

Inventors Bannister, Robin Mark; Baxter, Andrew Douglas; Brew, John

Agent Madderns

Pub. Number AU-B-2007222217

PCT Pub. Number WO2007/102019

Priority 0604824.3 09.03.06 GB

Filing date 9 March 2007

Wipo publication date 13 September 2007

Acceptance publication date 12 August 2010

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

2 October 2008 PCT application entered the National Phase

  PCT publication WO2007/102019 Priority application(s): WO2007/102019

1 April 2010 Assignment before Grant

  Sosei R & D Ltd. The application has been assigned to Biocopea Limited

12 August 2010 Application Accepted

  Published as AU-B-2007222217

9 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007222219-Electrical connection to impressed current anode in concrete construction

2007222209-The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain